Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. - Wikidata - awgldk - TriplyDB

Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.

Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.

http://www.wikidata.org/entity/Q34478724

about

Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein Antibodies for biodefense Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach Progress towards recombinant anti-infective antibodies.Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.Assessment of differences in the conformational flexibility of hepatitis B virus core-antigen and e-antigen by hydrogen deuterium exchange-mass spectrometry.ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections.Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.Chimpanzees as an animal model for human norovirus infection and vaccine development.Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis.Smallpox vaccines: targets of protective immunity.Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease.Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure.Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.Antibody responses to vaccinia membrane proteins after smallpox vaccination.Bayesian analysis of heterogeneity in the distribution of binding properties of immobilized surface sites Therapeutic and prophylactic drugs to treat orthopoxvirus infections Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement In vitro efficacy of ST246 against smallpox and monkeypox Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding.Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.Protective murine and human monoclonal antibodies against eczema vaccinatum Positive reactions on Western blots do not necessarily indicate the epitopes on antigens are continuous.

P2860

Q27647102-EB387309-4C16-4968-B72C-D0000137B85F Q28394941-923D8789-03B2-4949-80E6-F1BF3C1F694B Q30226522-32D92A2B-6DCE-438F-92C8-2E0E59074BE6 Q33302672-5822665B-F099-4B58-BB51-5DFCB2CF493C Q33351233-8709DC1F-26BC-4530-AE90-2E8DBC79E00E Q33568256-7ED58BCA-D77D-4A9A-A577-78DF4FB1D427 Q33827773-D9960B33-4334-4D6E-8DD9-4212ECF144A9 Q33870588-0ADE6D91-8744-470B-A893-44B2DCB2670D Q33892570-27FC45DB-6E89-4D84-ACFB-BEAD6A2FD4A2 Q33936717-9D594CC2-709D-441E-B430-8E3301F8A2E3 Q33967713-5568CB46-208E-47F2-BA43-F544640E8428 Q34447009-3E08C03B-5083-4EFE-98C7-7CBB918E3064 Q34469836-27D18535-1898-45DA-9019-D2B2FD386B6F Q34471908-C40D82D6-B076-47E6-832A-0D0D8D138CF3 Q34490786-3FBE01E5-B2A1-4550-83C5-8EBC16A6BBB1 Q34778430-9862F958-D93E-401C-9974-DB8E05E0DC85 Q34780607-257505AE-36E6-4F1B-A111-3F2BDA301D49 Q35339702-0E20746F-D898-4FF6-84E4-24F0C559EF90 Q35633065-47A58F96-5C4A-4E16-92C2-0F05B8E28813 Q35683735-2AFE4C65-D6F6-4866-B0D7-FD0BE5AE3E20 Q35948047-5214D3FC-1D24-4A4A-AE7A-C7B45E00AA12 Q35951545-606A9E3F-954F-401B-AF4F-334B41049C8F Q36023082-AE740997-3B6A-43E0-85FE-6221EF673EE2 Q36033286-4EE0E846-A67A-472C-A543-D20B9D74C706 Q36476453-045BBBBE-6ED0-4DA7-B795-399A4853A2E5 Q36498115-BF426CC9-A7F6-4164-9EE4-1EB7B3428EB6 Q36747784-895B1A7F-B9D2-4E8E-858F-61E92946D584 Q36856227-A66B4109-8290-40D9-B91D-A5CC41B4EEBF Q36869365-83F7CE8A-2AF1-4CC6-BFF5-FB9393D1963F Q36953458-B50E252B-6663-4B35-A142-E4766C35EDF7 Q37009973-FE266651-E712-4F8C-813A-03A708818427 Q37051617-320F4E33-10F1-41BC-A788-7C9F4D990EF9 Q37115752-B0333D69-719A-44BB-BD92-6B10C3587292 Q37304034-D1DBD99C-48DE-4A0A-BC7C-61C4DD7B7C95 Q37333457-447FBDDC-E7A6-4620-9211-D360810CFF63 Q37452067-215E3173-3E93-4AF5-BECF-999826FFDD1C Q37461110-91230602-5545-4E17-9521-6AAF0D437BC0 Q42633733-218E6C82-497A-4624-90F8-AD28B382FB98 Q42638248-F23BA790-FAB2-4E24-9208-73A65B80E426 Q45201742-6C150DF4-4C5E-4B41-B0BE-83FD91CD05DF

P2860

Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.

http://www.wikidata.org/entity/Q34478724

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@ast

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@en

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@nl

type

label

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@ast

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@en

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@nl

prefLabel

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@ast

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@en

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@nl

P1433

Q34478724-04FFCADA-AE73-45CF-A12D-63A498569811

P1476

Q34478724-A6C1F4C9-4AC4-4E9C-B87B-AA257D28E25C

P2093

Q34478724-0273950C-DDB6-43A3-86B6-52CCBE3D7469

Q34478724-10B45826-54B1-4C81-8726-B895BBEA17E2

Q34478724-2109F128-D452-4844-A5CD-6714A3ACD3FC

Q34478724-222073C3-5244-457D-9B09-480567FED784

Q34478724-2C9E6A82-183F-4496-AFA0-C35E8FE8414C

Q34478724-313776CF-5638-4CD6-AFF7-9E8B9FAC4048

Q34478724-4D9889FB-F201-46A5-BDDF-13AEBDF375FC

Q34478724-5460C9FD-5CB1-48AB-81A6-E90CCB48BF52

Q34478724-5E208CA2-4B1B-44A7-90B4-5B53CD398AB0

Q34478724-86792755-689B-4CA9-89A9-4B5560DE64D9

P2860

Q34478724-01EE6E45-ECDD-4550-8AF2-DF4CF76197B8

Q34478724-04AD94EC-CC42-4D9F-A9D5-26AEF01E4CB7

Q34478724-0E092CB2-09FF-45AF-A018-86B981C6BB05

Q34478724-0F8146FF-2194-43AF-A5B8-B34636DF5773

Q34478724-16A8B3E8-6772-4B6C-88F4-ED1BF07BEC61

Q34478724-19A914B1-3721-47D8-AEE9-F583C2A3B2CB

Q34478724-19D5A8FA-B38D-4845-9CF0-BE4C4E697E38

Q34478724-26D7AA44-445F-4DD1-A5FC-9DE9ED92D682

Q34478724-2838DB86-7D5D-4E88-B76D-C7CA8A294164

Q34478724-2E07204B-E34E-43BE-ADAC-A24912C6BE09

P304

Q34478724-BFD652A6-21D3-40E0-968E-6EBB488CC3E0

P31

Q34478724-0C401836-8475-4CA6-B87D-56DB17A9A1B2

P356

Q34478724-777678AB-CB61-4F31-AE86-416C2BDC00E7

P407

Q34478724-32A99F47-92B1-4212-9D6F-8BA0FE2E09F2

P433

Q34478724-C96ABFE2-7939-4D95-9BAB-8486F5E697F4

P478

Q34478724-D3166314-8D31-4E12-A645-74E9042C7A03

P50

Q34478724-29CE44A6-6D2F-4148-9A57-EE10DAC110B9

Q34478724-EB0A6E30-5525-482B-B148-EF1FAE175A37

P577

Q34478724-9B71811F-17B2-4FD7-BFF5-F3985288C965

P5875

Q34478724-B0E46E08-F9F8-4A98-96C1-8B3A8BE20B9C

P698

Q34478724-55FEA422-4BEB-4F09-A7B0-20BF66988D92

P921

Q34478724-8E3FD384-3E5C-48A3-85FF-BEEA7B07E86E

P932

Q34478724-D7C00FAA-1378-451E-88D3-D929C1815435

P356

PNAS.0510598103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Chimpanzee/human mAbs to vacci ...... t mice against vaccinia virus.

@en

P2093

Andrew Sebrell

http://www.w3.org/2001/XMLSchema#string

Fujuan Yu

http://www.w3.org/2001/XMLSchema#string

Gary Cohen

http://www.w3.org/2001/XMLSchema#string

Inger Damon

http://www.w3.org/2001/XMLSchema#string

Jeffrey Americo

http://www.w3.org/2001/XMLSchema#string

Juraj Svitel

http://www.w3.org/2001/XMLSchema#string

Patricia Earl

http://www.w3.org/2001/XMLSchema#string

Peter Schuck

http://www.w3.org/2001/XMLSchema#string

Robert Purcell

http://www.w3.org/2001/XMLSchema#string

Scott K Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Assembly of combinatorial antibody libraries on phage surfaces: the gene III site

Four chimpanzee monoclonal antibodies isolated by phage display neutralize hepatitis a virus.

Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.

The looming threat of bioterrorism.

Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge

The human immunoglobulin VH repertoire.

Smallpox vaccination: a review, part II. Adverse events.

Clinical efficacy of intramuscular vaccinia immune globulin: a literature review.

P304

1882-1887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0510598103

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Roselyn J. Eisenberg

P577

2006-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7336187

http://www.w3.org/2001/XMLSchema#string

P698

16436502

http://www.w3.org/2001/XMLSchema#string

P921

P932

1413659

http://www.w3.org/2001/XMLSchema#string